I'm a title. Click here to edit me

Press Release

Announcing SUMMIT breaking news

 IMI Diabetes Platform signs a Memorandum of Understanding

IMIDIA, DIRECT and SUMMIT take a step forward to further strengthen European diabetes research with the signature of their Memorandum of Understanding and with that increasing the interactions between the three IMI diabetes projects.

 

Click here for the full text of the press release

Navigation

MISSION

To DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:

  • the identification of patients at high risk of diabetes complications

  • the monitoring of the complications' progression and patients‘ response to therapy 

To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.



Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.

Related Sites

© 2014 by IMI-SUMMIT. All rights reserved.

Website design: Klodiana Jani